Letter from the CEO
It has been a year and ten months since the World Health Organization declared COVID-19 a pandemic. Despite the continuing pandemic, VIC’s business has largely returned to normal albeit with increased remote work, more...
Calvin Goforth, PhD
Recent Posts
University Technology Licensing Part 2: Assessing the Opportunities and Negotiating Licenses
Part 2: Technology Transfer and License Terms As was described in Part I of this article [1], VIC has a systematic and thorough technology assessment process. We also have extensive experience negotiating licenses for...
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
Part 1: Opportunity Sourcing and Assessment The U.S. invests more than $120 billion in federally sponsored research funding at universities and national labs. Technology Transfer Offices (TTOs) are unique entities...
Building Life Science Startups Beyond Traditional Venture Capital Hubs
Innovation is Geographically Distributed; Venture Capital Activity is Not The powerful combination of venture capital and innovation is critical to maintaining the global competitiveness of the U.S. While innovation is...
Zero Federal Capital Gains Taxes on High-Return Investments
With a new administration comes new perspectives and likely changes in tax policy. President Biden has proposed doubling the rate that wealthy Americans pay on investment capital gains up to 43.4%, a topic that has been...
Protecting Early Investors in Capital-Intensive Life Science Companies
Angel investors often invest at the seed stage of a company's development. The typically smaller round sizes and lower valuations allow early individual investors to gain a meaningful stake in a given company. However,...
A Letter from our CEO
When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...
VIC Investor Network Introduces a Secondary Market for Members
Provides VIN Members Early Liquidity Options FAYETTEVILLE, AR. DECEMBER 14, 2020- The VIC Investor Network (“VIN”) makes investments into companies based on technologies that can have substantial impact on human health...
VIC Foundry: An Incubator for High Impact Life Science Technologies
What is VIC Foundry? VIC Foundry is one element of the VIC innovation ecosystem. It develops technologies sourced from top research institutions in the U.S. with the potential to have substantial impact and commercial...
VIC 2020 Mid-Year Update
So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded...
